Related Experiment Video
Updated: Mar 25, 2026

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
MicroRNA-939 down-regulates CD2-associated protein by targeting promoter in HEK-293T cells
Yu-Ping Huang1, Ling-Zhi Qiu2, Guo-Ping Zhou1
1a Department of Pediatrics , the First Affiliated Hospital, Nanjing Medical University , Nanjing , Jiangsu , China ;
Abstract:
CD2-associated protein (CD2AP) serves as a slit diaphragm (SD) protein and plays essential roles in maintaining podocyte integrity and reducing proteinuria. MicroRNAs (miRNAs) are novel regulators of gene expression. Podocyte-specific loss of miRNAs would lead to significant proteinuria. Here, we report new evidence in which miRNAs may function to suppress CD2AP expression through a transcriptional way. By scanning human CD2AP promoter in silico for sequences complementary to known miRNAs, we chose miR-939, miR-148b*, miR-191*, miR-638 as four candidates and transfected them into HEK-293T cells. Dual-luciferase reporter assay identified that only miR-939 significantly reduced the relative luciferase activity of CD2AP promoter region. Further analysis confirmed that the mRNA and protein expressions of CD2AP were also down-regulated by miR-939. In conclusion, we have identified that miR-939 targets CD2AP promoter sequences and suppresses its gene expression. These findings suggest that miRNAs may mediate podocyte injury via reducing the expression of the SD proteins, such as CD2AP.
Insights
MicroRNAs (miRNAs) can suppress CD2-associated protein (CD2AP) expression transcriptionally. Specifically, miR-939 targets CD2AP promoter sequences, reducing CD2AP levels and potentially contributing to podocyte injury.
Area of Science:
- Molecular biology
- Genetics
- Nephrology
Background:
- CD2-associated protein (CD2AP) is crucial for maintaining podocyte integrity and preventing proteinuria.
- MicroRNAs (miRNAs) are key regulators of gene expression, and their loss in podocytes can cause significant proteinuria.
Purpose of the Study:
- To investigate the role of miRNAs in regulating CD2AP expression at the transcriptional level.
- To identify specific miRNAs that target and suppress CD2AP gene expression.
Main Methods:
- In silico analysis of the human CD2AP promoter for miRNA binding sites.
- Transfection of candidate miRNAs (miR-939, miR-148b*, miR-191*, miR-638) into HEK-293T cells.
- Dual-luciferase reporter assays to assess promoter activity.
- Analysis of mRNA and protein levels of CD2AP.
Main Results:
- miR-939 was identified as a miRNA that significantly reduces CD2AP promoter activity.
- miR-939 was confirmed to down-regulate both mRNA and protein expression of CD2AP.
- The study identified a transcriptional regulatory mechanism for CD2AP by miR-939.
Conclusions:
- miR-939 directly targets sequences within the CD2AP promoter, suppressing its gene expression.
- These findings suggest a novel mechanism by which miRNAs can contribute to podocyte injury by reducing essential slit diaphragm proteins like CD2AP.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Experimental RNAi
Regulation of Expression at Multiple Steps

